Literature DB >> 11864723

A transmission disequilibrium test of the Ser9/Gly dopamine D3 receptor gene polymorphism in adult attention-deficit hyperactivity disorder.

Pierandrea Muglia1, Umesh Jain, James L Kennedy.   

Abstract

Convincing data support the hypothesis that genetic factors are involved in the etiology of attention-deficit hyperactivity disorder (ADHD). Various lines of evidence have shown that the dopamine system plays a crucial role in the pathophysiology of ADHD. The dopamine D3 receptor gene (DRD3) represents a promising candidate to examine in ADHD. Animal studies have shown that DRD3 mRNA is highly expressed in the ventral striatum suggesting an involvement of this receptor in the control of motor behaviour. Manipulation of DRD3 in rodents has led to a mouse model with nonfunctional D3 receptors that displays hyperactive behaviour in various environmental conditions. Furthermore, administration of 7-OH-DPAT, a dopaminergic agonist that binds preferentially to D3 receptors exerts an inhibitory effect on locomotor activity while D3 antagonists induce hyperactivity. Among various polymorphisms described for DRD3, the BalI polymorphism is most interesting because it codes for an aminoacid substitution in the N-terminus of the receptor. The receptor products of the two alleles (Ser/Gly) exhibit differential affinity for dopamine. To determine if DRD3 Ser9/Gly is involved in the susceptibility to ADHD we genotyped 39 adults with ADHD and their respective parents (trios). Adult ADHD represents a promising phenotype for studying the genetic component of the disorder. In fact, a recent family study has shown that relatives of adult ADHD patients have a higher rate of ADHD compared to relatives of children with ADHD suggesting a stronger genetic component for the adult version. The results of genotyping in the 39 trios analyzed with the transmission disequilibrium test showed no excess of transmission for DRD3 MscI/BalI alleles (chi(2) = 0.360; df = 1; P = 0.54). This result, although from a relatively small sample, indicates that it is unlikely that DRD3 is playing a major role in the etiology of ADHD in our sample.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864723     DOI: 10.1016/s0166-4328(01)00438-7

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  14 in total

1.  Two quantitative trait loci for prepulse inhibition of startle identified on mouse chromosome 16 using chromosome substitution strains.

Authors:  Tracey L Petryshen; Andrew Kirby; Ronald P Hammer; Shaun Purcell; Sinead B O'Leary; Jonathan B Singer; Annie E Hill; Joseph H Nadeau; Mark J Daly; Pamela Sklar
Journal:  Genetics       Date:  2005-07-05       Impact factor: 4.562

Review 2.  From dopaminergic genes to psychiatric disorders.

Authors:  Janet Hoenicka; María Aragüés; Guillermo Ponce; Roberto Rodríguez-Jiménez; Miguel A Jiménez-Arriero; Tomás Palomo
Journal:  Neurotox Res       Date:  2007-01       Impact factor: 3.911

Review 3.  Role of dopamine receptors in ADHD: a systematic meta-analysis.

Authors:  Jing Wu; Haifan Xiao; Hongjuan Sun; Li Zou; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-05-19       Impact factor: 5.590

4.  DRD3 Gene and ADHD: A Pharmaco-Behavioural Genetic Study.

Authors:  Weam Fageera; Sarojini M Sengupta; Aurelie Labbe; Natalie Grizenko; Ridha Joober
Journal:  Neuromolecular Med       Date:  2018-07-26       Impact factor: 3.843

5.  Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?

Authors:  M Urhan-Kucuk; M E Erdal; M E Ozen; S Kul; H Herken
Journal:  Mol Biol Rep       Date:  2010-11-26       Impact factor: 2.316

Review 6.  Dopamine genes and attention-deficit hyperactivity disorder: a review.

Authors:  Salvatore DiMaio; Nathalie Grizenko; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

Review 7.  Molecular genetics of attention deficit hyperactivity disorder.

Authors:  Stephen V Faraone; Eric Mick
Journal:  Psychiatr Clin North Am       Date:  2010-03

8.  Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.

Authors:  Maurits E L Arbouw; Kris L L Movig; Toine C G Egberts; Petra J E Poels; Jeroen P P van Vugt; Judith A M Wessels; R J H M van der Straaten; Cees Neef; Henk-Jan Guchelaar
Journal:  Eur J Clin Pharmacol       Date:  2009-12       Impact factor: 2.953

9.  Association study between the dopamine-related candidate gene polymorphisms and ADHD among Saudi Arabia population via PCR technique.

Authors:  Adel E El-Tarras; Adnan A Alsulaimani; Nabil S Awad; Nahla Mitwaly; Manal M Said; Ayman M Sabry
Journal:  Mol Biol Rep       Date:  2012-10-18       Impact factor: 2.316

10.  Multivariate genomewide linkage scan of neurocognitive traits and ADHD symptoms: suggestive linkage to 3q13.

Authors:  Alysa E Doyle; Manuel A R Ferreira; Pamela B Sklar; Jessica Lasky-Su; Carter Petty; Steven J Fusillo; Larry J Seidman; Erik G Willcutt; Jordan W Smoller; Shaun Purcell; Joseph Biederman; Stephen V Faraone
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.